CODX 8-K 2026-11-10

Co-Diagnostics, Inc. (CODX) 8-K dated 2026-11-10 — accession 0001493152-26-050868.

Co-Diagnostics, Inc. (CODX) is a medical devices company listed on US.

CODX: Reports Third Quarter 2026 Financial Results

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CODX revenue for 2025-12-31 was $622.5K. Net income was -$46.9M. Revenue was down 84.1% from 2024-12-31 to 2025-12-31. CODX currently screens at market cap $31.4M.

Not investment advice. The CODX SEC hub lists recent forms. The stock page is the research view.